IVtoGo is produced by Cascade Biological, an Oregon, USA-based biotechnology company focused on improving access to high-dose, effective supplements for those with unmet medical needs. Its innovative solutions focus on liposomally encapsulated nutraceuticals that make complex treatment alternatives both more convenient and economical.
Cascade's organizational philosophy is founded on three ideas:
- In all we do, focus on consumer/patient convenience, quality of life, and outcomes.
- Use the purest ingredients and inputs available on the worldwide market.
- Treat all - suppliers, customers, employees, and contractors - with fairness and decency.
Premier formulations are the bedrock of IVtoGo. Cascade's Head of Formulations, Aaron Beitler, holds degrees from the University of Puget Sound and Oregon State University, and is a member of the American Chemical Society Division of Polymer Chemistry and the American Nano Society.
Cascade Biological actively works with leading researchers in both the USA and Europe in the formulation its products.
Pipeline: Continuing in the path of the original IVtoGo IV-replicant formulations, in 2022 Cascade Biological will introduce new, innovative products that will provide convenience and therapeutic efficacy to critically under-served segments of the medical population.
Thank you for visiting IVtoGo. For more information, feel free to contact us here; someone will be right with you.